Grifols, S.A. American Depositary Receipt Logo

Grifols, S.A. American Depositary Receipt (GRFS)

NASDAQ

Currency in USD
7.99
-0.01 (-0.13%)

Real-time Data

01:30 PM

Day's Range

7.94
8.03

52 wk Range

6.96
10.23

Profile - GRFS - Grifols, S.A. American Depositary Receipt

Profile

Mic Code

XNGS

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

23.80K


Grifols S.A. is a Spanish multinational pharmaceutical and chemical manufacturer that operates internationally, focusing on innovative solutions in the health sector. The company is known for specializing in the production of plasma-derived medicines, transfusion medicine, and clinical diagnostics. Through its comprehensive expertise, Grifols contributes significantly to the biopharmaceutical industry, playing a crucial role in enhancing the quality of life for patients with chronic and rare diseases. The company's operations are divided into several key divisions: Bioscience, Diagnostic, Hospital, and Bio Supplies, each contributing to its comprehensive healthcare offerings. Grifols’ expansive plasma donation network supports its vertically integrated business model, allowing for the efficient and sustainable production of life-saving products. Headquartered in Barcelona, it is a pivotal player in the healthcare market, enhancing healthcare delivery through biotechnology. Its presence spans across various countries, barely spanning critical industries such as transfusion medicine and biological products, where it continues to provide essential support for global health systems.

Profile Details

Type

American Depositary Receipt

Address

Avinguda de la Generalitat 152-158

City

Barcelona

Zip

08174

Country

Spain

Phone

34 935 712 200

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.